NEW YORK (GenomeWeb News) – Rosetta Genomics today said it has received full payment from Sanra Laboratories to settle a dispute over Sanra's purchase of Parkway Clinical Laboratories from Rosetta in 2009.

Sanra paid Rosetta $625,000 as part of the settlement announced last month between the firms. Under the terms of the agreement, Sanra agreed to pay Rosetta $625,000 on top of all other payments it has paid Rosetta "for total consideration of all their obligations." Sanra previously paid Rosetta $10,000 up front.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.